Note: This column describes the author’s own experiences with, or observations of, several medications. Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. I have eosinophilic granulomatosis with polyangiitis (EGPA), a type of ANCA-associated vasculitis (AAV) that is not indicated…
Long-term treatment with Nucala (mepolizumab) was linked to systemic disease remission in more than 90% of people with eosinophilic granulomatosis with polyangiitis (EGPA) in a real-world study in Italy, but sinonasal disease often persisted. Sinonasal manifestations affect the nasal cavity and the paranasal sinuses, the air-filled spaces within…
Older adults with ANCA-associated vasculitis (AAV) may achieve more favorable outcomes when induction therapy — an often intensive treatment approach aimed at quickly bringing active disease under control — is tailored to frailty and disease severity, a study suggests. Among adults ages 75 and older with severe active AAV…
Becoming educated and informed about ANCA vasculitis is a good first step. Here you’ll find general information such as the diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your ANCA vasculitis journey.
There is no cure for ANCA vasculitis yet, but here you can find more information about current approved treatments, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
